HRMY Q4 2021 Earnings — Harmony Biosciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena

HRMYHarmony Biosciences Holdings, Inc.

$2B

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$91M+62.0% YoY

Gross Profit

$73M80.5% margin

Operating Income

$29M31.4% margin

Net Income

$23M24.9% margin

EPS (Diluted)

$0.38

QoQ Revenue Growth

+13.0%

Cash Flow

Operating Cash Flow

$38M

Free Cash Flow

$38M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$433M

Total Liabilities

$247M

Stockholders' Equity

$187M

Cash & Equivalents

$234M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$91M	$56M	+62.0%
Gross Profit	$73M	$46M	+58.3%
Operating Income	$29M	$8M	+269.1%
Net Income	$23M	-$208,000	+11020.2%